Welcome to LookChem.com Sign In|Join Free
  • or
Benzenesulfonamide,N-1H-benzimidazol-2-yl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

13068-57-0

Post Buying Request

13068-57-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13068-57-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13068-57-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,6 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13068-57:
(7*1)+(6*3)+(5*0)+(4*6)+(3*8)+(2*5)+(1*7)=90
90 % 10 = 0
So 13068-57-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H11N3O2S/c17-19(18,10-6-2-1-3-7-10)16-13-14-11-8-4-5-9-12(11)15-13/h1-9H,(H2,14,15,16)

13068-57-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(1H-benzimidazol-2-yl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names 2-Benzolsulfonylamino-benzimidazol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13068-57-0 SDS

13068-57-0Downstream Products

13068-57-0Relevant academic research and scientific papers

Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents

Bocanegra-Garcia, Virgilio,Villalobos-Rocha, Juan Carlos,Nogueda-Torres, Benjamín,Lemus-Hernandez, María Edith,Camargo-Ordo?ez, Argelia,Rosas-Garcia, Ninfa Maria,Rivera, Gildardo

, p. 1039 - 1044 (2013/01/15)

Chagas disease continues to be one of the main parasitic diseases in Latin America. Despite the fact that it was discovered more than 100 years ago, no suitable pharmacologic treatment is available. We report the synthesis of new sulfonamidoquinoline and sulfonamides derivatives that were evaluated in vitro against two strains of Trypanosoma cruzi (NINOA and INC-5). Structure-activity relationship analysis indicated that small aromatic and large aromatic substituents on 4-aminoquinaldine increased trypanocidal activity on INC-5 and NINOA strains, respectively. Additionally, results show the importance of the sulfonamide group as a scaffold for the development of new anti-T. cruzi agents. Seven sulfonamide derivatives showed better lytic activity than nifurtimox and beznidazole against both strains of T. cruzi. N- (biphenyl-4-yl-sulfonyl)- nicotinamide (P-012) was established as the leader of the series for the development of more effective agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13068-57-0